Abstract
Our previous analyses in postmortem prefrontal cortex samples from a well-characterized cohort of severely affected schizophrenics and in matched controls demonstrated decreased expression of myelin and oligodendrocyte-related genes in the disease state. This decreased expression, now replicated in independent studies, suggests that there is a disruption of oligodendrocyte function and/or a loss of oligodendrocytes in schizophrenia. In the current report, we review expression studies in schizophrenia and present data demonstrating consistently fewer oligodendrocytes in schizophrenics compared to controls. The decrease in density reached 22% (p < 0.01) in layer III of area 9 and 20% (p < 0.02) in the white matter of the superior frontal gyrus. These data, when taken together with expression studies carried out by us and by other groups, and by imaging and other microscopic studies, point to a major involvement of oligodendrocyte abnormalities in schizophrenia. Therapies modulating oligodendrocyte survival and differentiation may therefore be beneficial in schizophrenia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Goldman-Rakic, P. S. and Selemon, L. D. 1997. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr. Bull. 23:437-458.
Bunney, W. E. and Bunney, B. G. 2000. Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. Brain Res. Brain Res. Rev. 31:138-146.
Hakak, J., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., and Fienberg, A. A. 2001. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. USA. 98:4746-4751.
Barres, B. A. and Raff, M. C. 1999. Axonal control of oligodendrocyte development. J. Cell Biol. 147:1123-1128.
Calaora, V., Rogister, B., Bismuth, K., Murray, K., Brandt, H., Leprince, P., Marchionni, M., and Dubois-Dalcq, M. 2001. Neuregulin signaling regulates neural precursor growth and the generation of oligodendrocytes in vitro. J. Neurosci. 21:4740-4751.
Mirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A., and Levitt, P. 2000. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28:53-67.
Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A., and Levitt, P. 2001. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol. Psychiatry 6:293-301.
Mirnics, K., Middleton, F. A., Lewis, D. A., and Levitt, P. 2001. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci. 24:479-486.
Middleton, F. A., Mirnics, K., Pierri, J. N., Lewis, D. A., and Levitt, P. 2002. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J. Neurosci. 22: 2719-2729.
Vawter, M. P., Barrett, T., Cheadle, C., Sokolov, B. P., Wood, W. H., Donovan, D. M., Webster, M., Freed, W. J., and Becker, K. G. 2001. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res. Bull. 55:641-650.
Mimmack, M. L., Ryan, M., Baba, H., Navarro-Ruiz, J., Iritani, S., Faull, R. L. M., McKenna P. J., Jones, P. B., Arai, H., Starkey, M., Emson, P. C., and Bahn, S. 2002. Gene expression analysis in schizophrenia: Reproducible up-regulation of several members of the apolipoprotein L family located in a highsusceptibility locus for schizophrenia on chromosome 22. Proc. Natl. Acad. Sci. USA. 99:4680-4685.
Copland, C., Dracheva, S., Davis, K. L., and Haroutunian, V. 2002. mRNA expression of three isoforms of myelin associated glycoprotein (MAG) in patients with schizophrenia. Soc. Neurosci. Abs., in press.
Purohit, D. P., Perl, D. P., Haroutunian, V., Powchik, P., Davidson, M., and Davis, K. L. 1998. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: A postmortem neuropathologic study of 100 cases. Arch. Gen. Psychiatry 55:205-211.
Perl, D. P., Good, P. F., Bussière, T., Morrison, J. H., Erwin, J. M., and Hof, P. R. 2000. Practical approaches to stereology in the setting of aging-and disease-related brain banks. J. Chem. Neuroanat. 20:7-19.
Nimchinsky, E. A., Young, W. G., Yeung, G., Shah, R. A., Gordon, J. W., Bloom, F. E., Morrison, J. H., and Hof, P. R. 2000. Differential vulnerability of oculomotor, facial, and hypoglossal nuclei in G86R superoxide dismutase transgenic mice. J. Comp. Neurol. 416:112-125.
West, M. J., Slomianka, L., and Gundersen, H. J. G. 1991. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231:482-497.
Schmitz, C. and Hof, P. R. 2000. Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach. J. Chem. Neuroanat. 20:93-114.
Miyakawa, T., Sumiyoshi, S., Deshimaru, M., Suzuki, T., and Tomonari, H. (1972) Electron microscopic study on schizophrenia. Mechanism of pathological changes. Acta Neuropathol. (Berl.) 20:67-77.
Uranova, N., Orlovskaya, D., Vikhreva, O., Zimina, I., Kolomeets, N., Vostrikov, V., and Rachmanova, V. 2001. Electron microscopy of oligodendroglia in severe mental illness. Brain Res. Bull. 55:597-610.
Buchsbaum, M. S., Tang, C. Y., Peled, S., Gudbjartsson, H., Lu, D., Hazlett, E. A., Downhill, J., Haznedar, M., Fallon, J. H., and Atlas, S. W. 1998. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport 9:425-430.
Lim, K. O., Hedehus, M., Moseley, M., de Crespigny, A., Sulivan, E. V., and Pfefferbaum, A. (1999) Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch. Gen. Psychiatry 56:367-374.
Foong, J., Maier, M., Barker, G. J., Brocklehurst, S., Miller, D. H., and Ron M. A. 2000. In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging. J. Neurol. Neurosurg. Psychiatry 68:70-74.
Foong, J., Symms, M. R., Barker, G. J., Maier, M., Woermann, F. G., Miller, D. H., and Ron, M. A. 2001. Neuropathological abnormalities in schizophrenia: Evidence from magnetization transfer imaging. Brain 124:882-892.
Benes, F. M. 1989. Myelination of cortical-hippocampal relays during late adolescence. Schizophr. Bull. 15:585-93.
Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., Chou, T. T., Hjaltason, O., Birgisdottir, B., Jonsson, H., Gudnadottir, V. G., Gudmundsdottir, E., Bjornsson, A., Ingvarsson, B., Ingason, A., Sigfusson, S., Hardardottir, H., Harvey, R. P. Lai, D., Zhou, M., Brunner, D., Mutel, V., Gonzalo, A., Lemke, G., Sainz, J., Johannesson, G., Andresson, T., Gudbjartsson, D., Manolescu, A., Frigge, M. L., Gurney, M. E., Kong, A., Gulcher, J. R., Petursson, H., and Stefansson, K. 2002. Neuregulin 1 and Susceptibility to Schizophrenia. Am. J. Hum. Genet. 71:877-892.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hof, P.R., Haroutunian, V., Copland, C. et al. Molecular and Cellular Evidence for an Oligodendrocyte Abnormality in Schizophrenia. Neurochem Res 27, 1193–1200 (2002). https://doi.org/10.1023/A:1020981510759
Issue Date:
DOI: https://doi.org/10.1023/A:1020981510759